Journal article
Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial
MC Pitman, N Meagher, DJ Price, A Rhodes, JJ Chang, B Scher, B Allan, A Street, JH McMahon, TA Rasmussen, PU Cameron, JF Hoy, SJ Kent, SR Lewin
Journal of Virus Eradication | MEDISCRIPT LTD | Published : 2023
Abstract
Introduction: Antiretroviral therapy for people living with HIV-1 must be taken lifelong due to the persistence of latent virus in long-lived and proliferating CD4+ T cells. Vitamin D3 is a steroidal gene transcription regulator which exerts diverse effects on immune and epithelial cells including reductions in CD4+ T cell proliferation and improvement in gut barrier integrity. We hypothesised that a high dose of vitamin D3 would reduce the size of the HIV-1 reservoir by reducing CD4+ T cell proliferation. Methods: We performed a randomised placebo-controlled trial evaluating the effect of 24 weeks of vitamin D3 (10,000 international units per day) on the HIV-1 reservoir and immunologic para..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
<B>Funding</B> This work was supported by the National Health and Medical Research Council (Program Grant number 1149990 to SRL and SJK) . The funding body had no role in study design, data collection, analysis or interpretation, manuscript writing or the decision to submit for publication.